Aripiprazole Research Overview
Aripiprazole is an atypical antipsychotic compound developed by Bristol-Myers Squibb for laboratory investigation of dopamine receptor modulation mechanisms. This pharmaceutical-grade research material enables scientists to examine partial agonism at D2 and D3 dopamine receptors, alongside 5-HT1A serotonin receptor interactions in controlled research environments. The compound’s unique pharmacological profile makes it valuable for studying neurotransmitter balance and receptor binding affinity. Research teams investigating neurochemical pathways can obtain this compound from our Stroid UK Shop, ensuring consistent quality for experimental protocols.
Laboratory Research Applications
Scientists evaluate aripiprazole in diverse neuropharmacological studies examining dopamine-serotonin interaction models. Research applications include investigating partial agonism mechanisms, studying receptor stabilisation theories, and examining antipsychotic drug development pathways. The compound’s distinct pharmacokinetic properties provide valuable data for researchers studying CNS drug metabolism and distribution patterns. Laboratory teams can explore this compound alongside other research materials available in our antipsychotic research collection. Comparative studies often examine this compound relative to other neuropharmacological agents, including novel compounds found in our selective receptor modulator range and bioactive research materials in our peptide research category.
Compound Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one |
| CAS Number | 129722-12-9 |
| Molecular Formula | C₂₃H₂₇Cl₂N₃O₂ |
| Molecular Weight | 448.39 g/mol |
| Dosage Strength | 10mg per tablet |
| Manufacturer | Bristol-Myers Squibb |
| Form | Oral tablets |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
This aripiprazole research material is supplied exclusively for in-vitro laboratory research and analytical purposes. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure appropriate laboratory safety protocols and comply with institutional guidelines when handling this pharmaceutical research compound. All studies should be conducted within approved research facilities with proper documentation and oversight.
